Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors

Essentials Intracranial hemorrhage (ICH) is common in patients with brain tumors. We compared rates of ICH with DOACs and low molecular weight heparin. DOACs were associated with a lower incidence of ICH in primary brain tumors. DOACs appear safe to administer to patients with brain tumors.

[1]  G. Lyman,et al.  Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D). , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  G. Raskob,et al.  Edoxaban for the Treatment of Cancer‐Associated Venous Thromboembolism , 2017, The New England journal of medicine.

[3]  D. Neuberg,et al.  Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin. , 2017, Blood.

[4]  A. Khorana,et al.  Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed? , 2016, Thrombosis research.

[5]  J. Zwicker,et al.  A meta‐analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation , 2016, Journal of thrombosis and haemostasis : JTH.

[6]  J. Zwicker,et al.  Intracranial hemorrhage in cancer patients treated with anticoagulation. , 2016, Thrombosis Research.

[7]  A. Khorana,et al.  Intracranial hemorrhage in setting of glioblastoma with venous thromboembolism , 2015, Journal of the Neurological Sciences.

[8]  D. Neuberg,et al.  Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study. , 2015, Blood.

[9]  D. Atar,et al.  Apixaban versus warfarin in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[10]  G. Breithardt,et al.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.

[11]  D. Gerber,et al.  Management of venous thromboembolism in patients with primary and metastatic brain tumors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J. Broderick,et al.  Volume of Intracerebral Hemorrhage: A Powerful and Easy‐to‐Use Predictor of 30‐Day Mortality , 1993, Stroke.